Dr. Gad Getz is part of the Crazy 8 team studying a vaccine for childhood cancer predisposition syndromes.

Gad (Gaddy) Getz is an internationally acclaimed leader in cancer genomics and is pioneering widely used tools for analyzing cancer genomes. Getz is a core institute member of the Broad Institute of MIT and Harvard, where he directs the Cancer Genome Computational Analysis Group. Getz is a professor of pathology at Harvard Medical School, and he is a faculty member and director of bioinformatics in the Krantz Family Center for Cancer Research and Department of Pathology at Massachusetts General Hospital (MGH). He is also the inaugural incumbent of the Paul C. Zamecnik Chair in Oncology at the Krantz Family Center for Cancer Research at MGH.

The Getz Laboratory specializes in cancer genome analysis, which includes two major steps: characterization and interpretation. His lab is currently interested in studying the heterogeneity and clonal evolution of many types of different cancers; single-cell analysis of tumors and the tumor microenvironment; drivers of resistance to therapies; the proteogenomic analysis of tumors; the role of somatic mutations in normal tissues; and other facets of the cancer genome.